marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Synthetic Biologics Financial Ratios 2011-2024 | SYN
Annual Financial Ratios Synthetic Biologics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.8 | -0.7 | -0.2 | -1.5 | -0.6 | -0.3 | -4.1 | -2.9 | -2.9 | -5.3 | -7.0 | -3.8 | -7.3 |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.1 | -1.3 | -1.9 | -0.7 | -1.0 | -4.1 | -0.2 | -0.3 | -0.5 | -0.3 | -0.3 | -0.5 | -0.3 |
EV (Enterprise Value) |
7.81 M | -9.77 M | -59.4 M | 11.9 M | -749 K | -21.3 M | 67.3 M | 79.5 M | 123 M | 96.7 M | 73.2 M | 55 M | 53.6 M |
EBITDA per Share |
-1.32 | -1.4 | -1.16 | -0.513 | -0.938 | -2.78 | -7.32 | -14.5 | -17.7 | -11.6 | -9.42 | -17.3 | -7.23 |
EV/EBITDA |
4.4 | -0.9 | 0.4 | 1.4 | -1.7 | -1.5 | -2.6 | -4.3 | -5.9 | -3.2 | -9.3 | ||
PEG |
-0.14 | 0.14 | 0.01 | -0.05 | -0.01 | -0.01 | -0.11 | -0.06 | 0.04 | 0.29 | -0.16 | 0.05 | 0.03 |
P/B |
0.4 | 0.3 | 0.0 | 1.9 | 0.6 | 0.1 | -41.6 | 20.4 | 8.0 | 11.0 | 5.7 | 5.0 | 8.5 |
P/CF |
-0.8 | -0.8 | -0.2 | -1.2 | -0.6 | -0.2 | -3.0 | -2.7 | -3.3 | -6.5 | -11.2 | -7.2 | -20.8 |
ROE % |
-49.64 | -37.98 | -21.81 | -125.05 | -106.53 | -45.52 | 1014.30 | -708.84 | -272.49 | -207.03 | -80.87 | -131.01 | -115.44 |
ROA % |
-33.23 | -27.39 | -20.28 | -119.42 | -88.79 | -44.35 | -80.55 | -121.14 | -141.80 | -103.34 | -75.76 | -127.15 | -109.00 |
ROCE % |
-57.98 | -41.64 | -21.82 | -186.63 | -130.96 | -65.67 | -290.23 | -1432.03 | -268.37 | -214.55 | -81.02 | -132.78 | -83.98 |
Current Ratio |
3.6 | 4.2 | 14.2 | 2.7 | 3.1 | 8.7 | 1.8 | 1.1 | 1.9 | 2.0 | 15.8 | 31.6 | 17.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Synthetic Biologics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-6.81 | -0.43 | -0.3 | - | -4.85 | -0.34 | -0.3 | - | -0.3 | -0.28 | -0.31 | - | -0.25 | -0.24 | -0.13 | - | -0.14 | -0.18 | -0.2 | - | -0.31 | -0.23 | -0.25 | -1.12 | -0.93 | -1.16 | -0.65 | 0.76 | -4.9 | -1.05 | -0.7 | -0.02 | -0.09 | -0.06 | -0.12 | -0.12 | -0.08 | -0.19 | -0.17 | -0.1 | -0.08 | -0.08 | -0.07 | -0.08 | -0.08 | -0.06 | -0.05 | - | -0.05 | -0.05 | -0.04 | - | -0.04 | -0.06 | -0.09 |
EBITDA per Share |
- | - | -0.31 | - | - | - | -0.34 | - | -0.31 | -0.31 | -0.31 | - | -0.24 | -0.24 | -0.03 | - | -0.1 | -0.15 | -0.17 | - | -0.3 | -0.21 | -0.22 | - | -1.02 | -1.32 | -1.34 | - | -1.55 | -1.81 | -2.41 | - | -0.1 | -0.1 | -0.12 | - | -0.14 | -0.13 | -0.11 | - | -0.08 | -0.08 | -0.07 | - | -0.07 | - | - | - | - | - | - | - | -0.03 | -0.03 | - |
ROE % |
-87.95 | -64.62 | -43.80 | -28.68 | -36.64 | -36.58 | -32.48 | -21.44 | -26.08 | -22.75 | -19.89 | -12.27 | 31.84 | 80.60 | 145.07 | 166.44 | -114.73 | -440.01 | -694.06 | -667.93 | -686.64 | -427.03 | -257.73 | -78.43 | -247.69 | 504.48 | 817.51 | 1035.49 | 1159.17 | 207.78 | -230.57 | -723.09 | -729.18 | -555.17 | -490.13 | -279.02 | -276.45 | -281.06 | -243.87 | -207.03 | -166.96 | -137.70 | -106.41 | -80.88 | -67.95 | -60.65 | -58.63 | -38.39 | -53.95 | -54.69 | -64.12 | -70.32 | -15.55 | -23.80 | -30.97 |
ROA % |
-54.85 | -40.95 | -29.10 | -19.73 | -25.44 | -25.78 | -23.45 | -15.94 | -20.30 | -18.95 | -17.65 | -11.70 | -36.71 | -57.36 | -87.31 | -94.34 | -124.05 | -128.75 | -115.15 | -70.57 | -81.17 | -63.67 | -57.11 | -44.41 | -18.89 | -64.71 | -73.68 | -82.23 | -108.15 | -87.86 | -90.57 | -123.58 | -149.21 | -135.82 | -154.37 | -145.19 | -142.42 | -143.73 | -123.36 | -103.34 | -95.48 | -90.55 | -82.11 | -75.77 | -64.16 | -57.82 | -56.41 | -37.26 | -51.95 | -52.26 | -60.79 | -66.40 | -14.69 | -22.47 | -29.24 |
ROCE % |
-92.22 | -70.45 | -50.61 | -34.00 | -42.84 | -41.43 | -36.58 | -23.17 | -27.81 | -23.61 | -19.87 | -12.28 | 32.00 | 80.93 | 145.87 | 168.41 | -119.46 | -451.60 | -711.99 | -683.80 | -709.11 | -446.56 | -276.09 | -83.86 | 306.65 | 722.47 | 1184.60 | 1368.05 | 1129.92 | 501.29 | -173.69 | -755.47 | -828.06 | -662.51 | -480.97 | -184.33 | -235.72 | -214.53 | -202.59 | -140.24 | -162.33 | -133.03 | -84.36 | -22.09 | -22.09 | - | - | - | -13.29 | -26.58 | -39.61 | - | -13.29 | -13.03 | - |
Current Ratio |
2.6 | 2.9 | 3.3 | 3.6 | 3.5 | 3.7 | 3.9 | 4.2 | 3.8 | 4.0 | 4.2 | 14.2 | 16.5 | 21.9 | 35.5 | 2.7 | 2.7 | 2.7 | 2.7 | 3.0 | 3.0 | 3.0 | 3.0 | 8.2 | 8.2 | 8.2 | 8.2 | 1.9 | 1.9 | 1.9 | 1.9 | 1.1 | 1.1 | 1.1 | 1.1 | 1.9 | 1.9 | 1.9 | 1.9 | 2.0 | 2.0 | 2.0 | 2.0 | 15.8 | 15.8 | 71.0 | 15.8 | 34.0 | 34.0 | 34.0 | 30.3 | 17.9 | 17.9 | 17.9 | 17.9 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 126.0 | 103.9 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 126.0 | 103.9 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 126.0 | 103.9 | - |
All numbers in USD currency